Paul Hebeisen

This inventor holds 49 USPTO granted patents and 5 published patent applications, plus 8 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoffmann-La Roche Inc., Vernalis Research Limited, Piqur Therapeutics Ag. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Hebeisen. Retrieved from https://idiyas.com/inventor/paul-hebeisen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 (Patent Applications = 5)

% Patents Active = 42.9

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 19 (Patent Applications = 16)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 139(Granted Patents)

Location History:

Reinach, CH (1989 - 1996)
Basle, CH (1997)
Basie, CH (2003)
Basel, CH (1996 - 2024)

Company Filing History:

38 out of 5,024

Hoffmann-La Roche Inc.

patents

6 out of 43

Vernalis Research Limited

patents

4 out of 4

Piqur Therapeutics Ag

Basilea Pharmaceutica Ag

University of Pennsylvania

patents

10. 1 out of 1

Vernal Research Limited

patent

11. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

Areas of Expertise:

Skin Lesions

Neurological Disorders

Obesity Treatments

Pyridine Derivatives

Pyrimidine Derivatives

Cholesterol Raising Agents

FBPase Inhibitors

Pyrazine Derivatives

Heteroarylmethyl Amides

Triazine Derivatives

5HT2C Agonists

Aminothiazoles

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11918586 - Treatment of skin lesions (2024-03-05),

2. 11878972 - Treatment of neurological disorders (2024-01-23),

3. 11186591 - Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines (2021-11-30),

4. 10993947 - Treatment of skin lesions (2021-05-04),

5. 10766874 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2020-09-08),

6. 10640516 - Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines (2020-05-05),

7. 10100031 - Manufacturing process for triazine, pyrimidine and pyridine derivatives (2018-10-16),

8. 9556203 - Conformationally restricted P13K and mTOR inhibitors (2017-01-31),

9. 9403808 - Pyrazine derivatives (2016-08-02),

10. 9321727 - Pyridine derivatives as agonists of the CB2 receptor (2016-04-26),

11. 9090599 - Heteroarylmethyl amides (2015-07-28),

12. 8729105 - Heteroarylmethyl amides (2014-05-20),

13. 8669254 - Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents (2014-03-11),

14. 8648099 - 3-pyridine carboxylic acid hydrazides (2014-02-11),

15. 8410107 - [object Object] (2013-04-02),

Title: The Innovative Mind of Paul Hebeisen

Introduction: Paul Hebeisen, a pioneering inventor hailing from Basel, Switzerland, has made significant contributions to the world of technology and innovation.

Latest Patents: Paul Hebeisen's latest patents include groundbreaking inventions in the field of renewable energy storage systems and advanced medical devices.

Career Highlights: With a career spanning over two decades, Paul Hebeisen has established himself as a leading figure in the innovation landscape. His work has been instrumental in shaping the future of sustainable technologies and cutting-edge medical advancements.

Collaborations: Throughout his career, Paul Hebeisen has collaborated with top research institutions, leading companies, and renowned universities to bring his innovative ideas to life. His collaborative efforts have resulted in transformative inventions that have had a lasting impact on various industries.

Conclusion: Paul Hebeisen's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of innovators to think boldly and create solutions that shape the world of tomorrow.

Profile summary based on public USPTO records.